| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal & Compliance
1 company
Rahsaan Thompson is Chief Legal & Compliance at ZVRA. Rahsaan Thompson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $385K at current prices.
Historically, Rahsaan Thompson's trades have earned a below-average insider score of 29/100 across 4 rated trades. Over a 12-month horizon, the one trade was not profitable, with an average 12-month return of -45.7%.
The ZVRA filings lean toward selling, a net 107,097 shares.
Rahsaan Thompson has 10 Form 4 filings on record from October 2022 to August 2026, across 2 companies: Chief Legal & Compliance at Zevra Therapeutics (ZVRA), 2024–2026; Chief Legal Officer at Lyell Immunopharma (LYEL), 2022–2023.
The 15 reported transactions were 7 option or other derivative awards, 5 open-market sales and 3 option exercises.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $1.2M.
The largest open-market sale was 42,666 shares of ZVRA at an average $11.13 on August 14, 2026, about $475K.
All 5 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | ZVRA Zevra Therapeutics, Inc. | Chief Legal & Compliance | Sell10b5-1 | 42,666 | $11.13 | $474,774.45 | -53.2% | - | - | |
| Jun 22, 2026 | ZVRA Zevra Therapeutics, Inc. | Chief Legal & Compliance | Sale+OE10b5-1 | 34,557 | $12.68 | $438,303.71 | -30.1% | -7.7% | - | |
| May 11, 2026 | ZVRA Zevra Therapeutics, Inc. | Chief Legal & Compliance | Sell10b5-1 | 1,794 | $11.30 | $20,272.20 | -3.6% | +6.3% | - | |
| Jan 30, 2026 | ZVRA Zevra Therapeutics, Inc. | Chief Legal & Compliance | Sale+OE10b5-1 | 4,080 | $8.83 | $36,009.67 | -7.6% | +13.0% | - | |
| Jun 26, 2025 | ZVRA Zevra Therapeutics, Inc. | Chief Legal & Compliance | Sell10b5-1 | 24,000 | $9.21 | $221,004.00 | -36.0% | -3.6% | +45.7% |